IL67646A0 - Ascorbic acid ethers and related compounds - Google Patents
Ascorbic acid ethers and related compoundsInfo
- Publication number
- IL67646A0 IL67646A0 IL67646A IL6764683A IL67646A0 IL 67646 A0 IL67646 A0 IL 67646A0 IL 67646 A IL67646 A IL 67646A IL 6764683 A IL6764683 A IL 6764683A IL 67646 A0 IL67646 A0 IL 67646A0
- Authority
- IL
- Israel
- Prior art keywords
- ascorbic acid
- related compounds
- acid ethers
- ethers
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33934482A | 1982-01-15 | 1982-01-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL67646A0 true IL67646A0 (en) | 1983-05-15 |
Family
ID=23328588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL67646A IL67646A0 (en) | 1982-01-15 | 1983-01-10 | Ascorbic acid ethers and related compounds |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0086554A1 (el) |
| JP (1) | JPS58131978A (el) |
| KR (1) | KR840003247A (el) |
| AU (1) | AU1035183A (el) |
| CA (1) | CA1181078A (el) |
| DD (1) | DD209455A5 (el) |
| DK (1) | DK14283A (el) |
| ES (2) | ES518968A0 (el) |
| FI (1) | FI830078L (el) |
| GB (1) | GB2114571A (el) |
| GR (1) | GR77897B (el) |
| IL (1) | IL67646A0 (el) |
| PL (1) | PL240125A1 (el) |
| PT (1) | PT76083B (el) |
| RO (1) | RO86439B (el) |
| ZA (1) | ZA83173B (el) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4552895A (en) * | 1983-03-14 | 1985-11-12 | Eli Lilly And Company | Furo[3,2-b]furan-2-(3H)-ones |
| JPS6058973A (ja) * | 1983-09-13 | 1985-04-05 | Mitsubishi Yuka Yakuhin Kk | γ−プチロラクトン誘導体及びそれを有効成分とする免疫調節剤 |
| WO1986007592A1 (en) * | 1985-06-18 | 1986-12-31 | Takeda Chemical Industries, Ltd. | Ascorbic acid derivatives, process for their preparation, and preparations containing same |
| WO1986006720A1 (en) * | 1985-05-17 | 1986-11-20 | Takeda Chemical Industries, Ltd. | Ascorbic acid derivatives, production thereof, and pharmaceutical preparation therefrom |
| JPS60130582A (ja) * | 1983-12-19 | 1985-07-12 | Takeda Chem Ind Ltd | 食品用酸化防止剤，アスコルビン酸誘導体およびその製造法 |
| JPS60139619A (ja) * | 1983-12-27 | 1985-07-24 | Mutsuyuki Kochi | Ｏ−ベンジリデン−アスコルビン酸又はその塩よりなる抗腫瘍剤 |
| JP2515556B2 (ja) * | 1986-08-29 | 1996-07-10 | 武田薬品工業株式会社 | ヒドロキシブテノライド誘導体およびその製造法 |
| JP2752080B2 (ja) * | 1988-03-09 | 1998-05-18 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びその製造方法並びにアスコルビン酸誘導体からなる抗酸化剤 |
| JPH0730066B2 (ja) * | 1988-03-09 | 1995-04-05 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びアスコルビン酸誘導体からなる抗酸化剤 |
| EP0359036B1 (en) | 1988-09-01 | 1997-03-26 | Takeda Chemical Industries, Ltd. | Fumagillol derivatives |
| US5194445A (en) * | 1989-09-11 | 1993-03-16 | Nippon Hypox Laboratories Incorporated | Ascorbic acid derivative |
| US5095126A (en) * | 1990-01-12 | 1992-03-10 | Ohio State University Research Foundation | Efficient synthesis for optically pure stereogenically labile 4-substituted-2-hydroxytetronic acids |
| DE59106126D1 (de) * | 1990-03-07 | 1995-09-07 | Hoffmann La Roche | Verfahren zur herstellung von derivaten der ascorbinsäure. |
| US5270336A (en) * | 1990-03-16 | 1993-12-14 | Merrell Dow Pharmaceuticals Inc. | Ascorbic acid derivatives |
| EP0446539A1 (en) * | 1990-03-16 | 1991-09-18 | Merrell Dow Pharmaceuticals Inc. | Novel ascorbic acid derivatives |
| JPH0429989A (ja) * | 1990-05-24 | 1992-01-31 | Nisshin Flour Milling Co Ltd | Ｌ―アスコルビン酸誘導体の製造法 |
| GB9026114D0 (en) * | 1990-11-30 | 1991-01-16 | Norsk Hydro As | New compounds |
| GB9201274D0 (en) * | 1992-01-21 | 1992-03-11 | Norsk Hydro As | New compounds |
| GB9201275D0 (en) * | 1992-01-21 | 1992-03-11 | Norsk Hydro As | New compounds |
| TW325997B (en) * | 1993-02-02 | 1998-02-01 | Senju Pharma Co | Pharmaceutical composition for preventing and treating retinal diseases |
| US6114355A (en) * | 1993-03-01 | 2000-09-05 | D'amato; Robert | Methods and compositions for inhibition of angiogenesis |
| US5629327A (en) | 1993-03-01 | 1997-05-13 | Childrens Hospital Medical Center Corp. | Methods and compositions for inhibition of angiogenesis |
| US6228879B1 (en) | 1997-10-16 | 2001-05-08 | The Children's Medical Center | Methods and compositions for inhibition of angiogenesis |
| US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
| US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
| DE69740095D1 (de) | 1996-11-05 | 2011-02-17 | Childrens Medical Center | Thalidomide und Dexamethason für die Behandlung von Tumors |
| EP0875246A1 (en) * | 1997-04-04 | 1998-11-04 | Showa Denko Kabushiki Kaisha | Pharmaceutical preparation of ascorbic acid derivatives for medical treatment of cancer |
| BR9909168A (pt) * | 1998-03-27 | 2000-12-05 | Lg Chemical Ltd | Derivados de ácido ascórbico polietoxilados como anti-oxidantes e processo para preparação dos mesmo |
| US6673828B1 (en) | 1998-05-11 | 2004-01-06 | Children's Medical Center Corporation | Analogs of 2-Phthalimidinoglutaric acid |
| US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
| WO2001056566A1 (fr) * | 2000-02-01 | 2001-08-09 | Mutsuyuki Kochi | Compositions inhibitrices de neovascularisation et procede correspondant |
| WO2001074369A1 (en) * | 2000-03-31 | 2001-10-11 | Angiogene Pharmaceuticals Ltd. | Divided dose therapies with vascular damaging activity |
| ATE322498T1 (de) * | 2001-07-26 | 2006-04-15 | Tagra Biotechnologies Ltd | Stabilisierte ascorbinsäure -3- phosphat- derivate |
| TWI330533B (en) | 2002-05-15 | 2010-09-21 | Bhn Co Ltd | Composition for angiogenesis inhibition, neoplasm inhibition,or immunostimulation |
| EP1939192A1 (en) * | 2006-12-28 | 2008-07-02 | Neuropharma S.A. | Cyclopentanone derivatives, method of synthesis and uses thereof |
| FR2955493B1 (fr) * | 2010-01-28 | 2012-02-24 | Oreal | Utilisation de derives d'acide ascorbique en coloration des fibres keratiniques humaines, composition les comprenant, procede de coloration et dispositif |
| JP5602456B2 (ja) * | 2010-02-24 | 2014-10-08 | 日本精化株式会社 | アスコルビン酸誘導体 |
| US9550744B2 (en) * | 2013-09-25 | 2017-01-24 | University Of Florida Research Foundation, Inc. | Vitamin C prodrugs and uses thereof |
| US10105407B2 (en) * | 2015-06-09 | 2018-10-23 | John P. Crow, JR. | Methods of extraction of nitrosylated or nitrated derivatives of ascorbic acid from myriciaria dubia and methods of synthesis thereof |
| EP3383429B1 (en) | 2015-11-30 | 2020-10-14 | INSERM - Institut National de la Santé et de la Recherche Médicale | Nmdar antagonists for the treatment of tumor angiogenesis |
-
1983
- 1983-01-10 IL IL67646A patent/IL67646A0/xx unknown
- 1983-01-10 FI FI830078A patent/FI830078L/fi not_active Application Discontinuation
- 1983-01-10 RO RO109663A patent/RO86439B/ro unknown
- 1983-01-11 PT PT76083A patent/PT76083B/pt unknown
- 1983-01-11 CA CA000419220A patent/CA1181078A/en not_active Expired
- 1983-01-11 ZA ZA83173A patent/ZA83173B/xx unknown
- 1983-01-12 PL PL24012583A patent/PL240125A1/xx unknown
- 1983-01-12 DD DD83247195A patent/DD209455A5/de unknown
- 1983-01-13 AU AU10351/83A patent/AU1035183A/en not_active Abandoned
- 1983-01-13 ES ES518968A patent/ES518968A0/es active Granted
- 1983-01-13 JP JP58005144A patent/JPS58131978A/ja active Pending
- 1983-01-13 EP EP83300174A patent/EP0086554A1/en not_active Ceased
- 1983-01-13 GR GR70253A patent/GR77897B/el unknown
- 1983-01-13 GB GB08300907A patent/GB2114571A/en not_active Withdrawn
- 1983-01-14 DK DK14283A patent/DK14283A/da not_active Application Discontinuation
- 1983-01-14 KR KR1019830000115A patent/KR840003247A/ko not_active Application Discontinuation
- 1983-08-30 ES ES525239A patent/ES8502698A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58131978A (ja) | 1983-08-06 |
| FI830078A0 (fi) | 1983-01-10 |
| AU1035183A (en) | 1983-07-21 |
| ES8403118A1 (es) | 1984-03-01 |
| RO86439A (ro) | 1985-03-15 |
| ES518968A0 (es) | 1984-03-01 |
| GB2114571A (en) | 1983-08-24 |
| ZA83173B (en) | 1984-08-29 |
| PL240125A1 (en) | 1984-04-24 |
| CA1181078A (en) | 1985-01-15 |
| ES525239A0 (es) | 1985-01-16 |
| GR77897B (el) | 1984-09-25 |
| RO86439B (ro) | 1985-03-31 |
| DK14283A (da) | 1983-07-16 |
| DD209455A5 (de) | 1984-05-09 |
| PT76083A (en) | 1983-02-01 |
| DK14283D0 (da) | 1983-01-14 |
| EP0086554A1 (en) | 1983-08-24 |
| FI830078L (fi) | 1983-07-16 |
| KR840003247A (ko) | 1984-08-20 |
| ES8502698A1 (es) | 1985-01-16 |
| GB8300907D0 (en) | 1983-02-16 |
| PT76083B (en) | 1986-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL67646A0 (en) | Ascorbic acid ethers and related compounds | |
| GB8300312D0 (en) | Circuitry | |
| GB8333203D0 (en) | Diaper | |
| GB8411259D0 (en) | Medicinal agent | |
| GB8313783D0 (en) | Bandage constructions | |
| GB8325337D0 (en) | Porphylactic substance | |
| DE3366682D1 (en) | Substituted pyridyl-phenyl ethers | |
| GB2134737B (en) | Amplifier | |
| GB8324194D0 (en) | Caster | |
| DE3360685D1 (en) | Antimycosic agent | |
| DE3370261D1 (en) | Amplifier | |
| GB8308451D0 (en) | Amplifier | |
| DE3361451D1 (en) | Fungicidal cyanopropenoates and compositions containing them | |
| PH18658A (en) | Ethers | |
| YU134983A (en) | Comutation amplifier | |
| IL69094A0 (en) | Ointment and its preparation | |
| GB2123413B (en) | Eburnane-oxime ethers | |
| GB8332554D0 (en) | Bandage | |
| GB2119787B (en) | Pyrones | |
| GB8306720D0 (en) | Amplifier | |
| ZA811286B (en) | Phenyl-alkylthio ethers | |
| GB2085443B (en) | Calcitroic acid and related compounds | |
| GB2368215B (en) | Ranging | |
| GB8314199D0 (en) | Axles | |
| ZA838562B (en) | Ethers |